Assignment of Assignor's Interest

Recorded: 2021-11-12 Pages: 5

Assignor

Executed: 2021-11-10

Assignee

ASKGENE PHARMA INC.

5217 VERDUGO WAY, SUITE A, CAMARILLO, CALIFORNIA, 93102

Covered Properties (2)

Novel Angiopoietin 2, VEGF Dual Antagonists

Patent: 10,654,922 →

Application: 15/593,280 →

Publication: US 2017/0327569

Novel Angiopoietin 2, VEGF Dual Antagonists

Patent: 11,746,147 →

Application: 16/741,686 →

Publication: US 2020/0131260

PCT: PCT/US2017/032289 ↗

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.